ObsEva S.A.
ObsEva S.A. (OBSV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OBSV · as of Jun 9, 2026
Key Statistics
Explore ObsEva S.A. Data
obsv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 69.2%
The OBSV analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +5793.91% upside from the current price of $0.10.
Competitors & Peers
obsv competitorsOBSV
AMTI
APGN
CYCC
GLS
HURAStock Performance
Full HistoryAbout ObsEva S.A.
ObsEva S.A. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing innovative treatments for conditions affecting women's reproductive health and pregnancy. A key part o…
what is obseva s.a. · obsv stock overview · obseva s.a. company profile · who is obseva s.a. ceo · obsv NASDAQ · obseva s.a. headquarters · obseva s.a. business segments
About Stock Overview & Key Data
ObsEva S.A. (OBSV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 13, 2018. As of the latest trading session, OBSV stock price is $0.10, with a market capitalization of $11.0M. The stock has returned -92.78% over the past 12 months and -35.16% year-to-date.
According to 13 Wall Street analysts, the consensus rating for ObsEva S.A. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2022, ObsEva S.A. reported revenue of $19.6M and net income of -$29.9M. For detailed data — including ObsEva S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ObsEva S.A. (OBSV) stock price is $0.10. The stock is traded on NASDAQ under the ticker symbol OBSV. The 52-week range is $0.07 – $2.14.